7KI0: Zhang X, Belousoff MJ, Liang YL, Danev R, Sexton PM, Wootten D
In 2025, Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes
F., Almarzoq, F
Comprehensive obesity and diabetes management extends beyond pharmacotherapy, incorporating medical nutrition therapy, physical activity (150 minutes weekly of moderate-intensity exercise), behavioral counseling, and treatment of comorbidities
Accumulating evidence supports a possible reduction in risk of hepatocellular carcinoma as well as oesophageal, endometrial, prostate and ovarian cancers in those receiving GLP1RAs
PubMedPMC 67